Champignon Brands Announces Contract Research Partner For Ketamine, Psilocybin IP Portfolio

Champignon Brands (CSE: SHRM) announced this morning that it is advancing its drug discovery program with the selection of Dalriada as the firms contract research organization. Dalriada will advance Champignon’s new chemical entity IP portfolio in the areas of ketamine and psilocybin molecular scaffolds.

The partnership with Dalriada is expected to bring a robust pipeline of preclinical and clinical assets to Champignon, with Dalriada also providing integrated research and development support to the firm. The announcement of the contract research organization is anticipated to accelerate existing preclinical assets as well as the currently ongoing development of proprietary delivery systems.

“Dalriada’s expertise in medicinal chemistry will be a monumental addition to Champignon’s innovative diverse formulation platforms by their expertise in the synthesis of molecules, including existing psychedelics (ketamine, psilocybin and MDMA), as well as novel new psychedelic-like molecules. This synergistic collaboration will differentiate Champignon from other companies in the psychedelic space by boosting our ability to maintain an inhouse infrastructure for the clinical delivery NCEs.”
Dr Joseph Gabriele, Special Advisor to Champignon

Daldriada is a contract research organization that provides provides a suite of services in the area of drug discovery, medicinal chemistry, and IP for lean biotech clients that are focused on developing small molecule therapies. The firms research and development operations are located in Mississauga, Ontario.

Champignon Brands last traded at $1.22 on the CSE.


FULL DISCLOSURE: Champignon Brands is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Champignon Brands on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Goliath Resources Hits 10.60 g/t Gold Over 22.82 Metres, Highest Grade Results In Third Distinct Rock Package At Surebet Discovery

Four Countries Control the Fertilizer That Feeds the World | Sage Potash

$10,000 Gold Is Just A Question of Time | Florian Grummes

Recommended

ESGold Outlines $24.3 Million NPV For Tailings Reprocessing Project

First Majestic Encounters 711 g/t Silver Equivalent Over 8.0 Metres In Ongoing Exploration At Los Gatos

Related News

Champignon Brands Signs Definitive Agreement To Acquire AltMed Capital

Champignon Brands (CSE: SHRM) has announced this evening that it will be acquiring alternative medicine...

Thursday, April 9, 2020, 09:03:04 PM

Champignon Brands Appoints Dr Roger McIntyre As CEO

Champignon Brands (CSE: SHRM) this morning announced that it has named Dr Roger McIntyre as...

Monday, May 11, 2020, 09:48:09 AM

Champignon Brands To Acquire Biotech Firm Novo Formulations

Champignon Brands (CSE: SHRM) announced today that they have signed a definitive agreement to acquire...

Thursday, March 19, 2020, 03:27:32 PM

Champignon Appoints Dr Bill Wilkerson To Board Of Directors

Champignon Brands (CSE: SHRM) this morning continued its ongoing process of strengthening its board of...

Monday, May 25, 2020, 08:29:55 AM

Champignon Brands To Change Name To Braxia Scientific

Champignon Brands (CSE: SHRM) is evidently looking to turn a new leaf, with the company...

Monday, May 3, 2021, 07:16:21 AM